Foley attorneys filed an amicus brief in the United States District Court for the Southern District of New York related to ACLU v. Myriad regarding subject matter patentability of gene patents specifically on isolated DNA. The authors conclude that the U.S. Congress, U.S. courts and the USPTO, as well as the scientific community and biotechnology industry have long relied upon an understanding that claims directed to “isolated DNA” recite patentable subject matter under 35 U.S.C. §101 and the Constitution. The authors maintain that to hold otherwise would have a dramatic negative effect on biotech research as we know it, and will influence the entire business of biotechnology in ways unforeseen or addressed by the plaintiffs in ACLU v. Myriad”
People
Related News
December 10, 2025
Press Releases
Foley Chairman and CEO Daljit Doogal Reelected to Second Term
Foley & Lardner LLP is pleased to announce that Daljit Doogal has been reelected to serve as Chairman and CEO for a second, four-year term beginning May 1, 2026, upon expiration of his current term, and effective through April 30, 2030.
November 18, 2025
Press Releases
Foley Announces Joe Dowdy as Raleigh Office Managing Partner
Foley & Lardner LLP has appointed litigator Joseph Dowdy as managing partner of the firm’s Raleigh, North Carolina, office.
October 20, 2025
Press Releases
Foley Welcomes 2025 New Associate Class
Foley & Lardner LLP welcomes its 2025 associate class—69 new lawyers and clerks across 18 offices and 16 practice areas—highlighting the firm’s nationwide commitment to top legal talent, professional development, and client service excellence.